Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells

Cell Biochemistry and Function

Volumn 26, Issue 3, 2008, Pages 381-391

  Omidi, Yadollah ^a,b   Barar, Jaleh ^a,b   Ahmadian, Somaieh ^b   Heidari, Hamid Reza ^b   Gumbleton, Mark ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amino acids transporters; Astrocytes; Blood brain barrier; System l

Indexed keywords

ALANINE; AMINO ACID TRANSPORTER; LAT PROTEIN; PHENYLALANINE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL CULTURE; COCULTURE; CULTURE MEDIUM; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

AMINO ACID TRANSPORT SYSTEM Y+; AMINO ACIDS; ANIMALS; ASTROCYTES; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; ISOMERISM; KINETICS; MICE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM; TEMPERATURE; TIME FACTORS;

EID: 42949091493     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1455     Document Type: Article

References (43)

1. Kang YS, Terasaki T, Ohnishi T, Tsuji A. In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier. J Pharmacobiodyn 1990; 13: 353-360.
2. Tsuji A, Tamai I. Carrier-mediated intestinal transport of drugs. Pharm Res 1996; 13: 963-977.
3. Smith QR. Drug delivery to brain and the role of carrier-mediated transport. Adv Exp Med Biol 1993; 331: 83-93.
4. Omidi Y, Gumbleton M. Biological membranes and barriers. In Biomaterials for Delivery and Targeting of Proteins Nucleic Acids, Mahato RI (ed). CRC Press: New York, 2005; 232-274.
5. Wagner CA, Lang F, Broer S. Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 2001; 281: C1077-C1093.
6. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A 1999; 96: 12079-12084.
7. Tsuji A, Tamai I. Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv Drug Deliv Rev 1999; 36: 277-290.
8. Verrey F. System L, heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 2003; 445: 529-533.
9. Pfeiffer R, Rossier G, Spindler B, et al. Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein- associated amino acid transporter family. EMBO J 1999; 18: 49-57.
10. Duelli R, Enerson BE, Gerhart DZ, Drewes LR. Expression of large amino acid transporter LAT1 in rat brain endothelium. J Cereb Blood Flow Metab 2000; 20: 1557-1562.
11. Prasad PD, Wang H, Huang W, et al. Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun 1999; 255: 283-288.
12. Kanai Y, Segawa H, Miyamoto K, et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998; 273: 23629-23632.
13. Kido Y, Tamai I, Uchino H, et al. Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier. J Pharm Pharmacol 2001; 53: 497-503.
14. Verrey F, Jack DL, Paulsen IT, Saier MH, Jr., Pfeiffer R. New glycoprotein-associated amino acid transporters. J Membr Biol 1999; 172: 181-192.
15. Verrey F, Meier C, Rossier G, Kuhn LC. Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity. Pflugers Arch 2000; 440: 503-512.
16. Balabanov R, Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res 1998; 53: 637-644.
17. Bauer HC, Bauer H. Neural induction of the blood-brain barrier: still an enigma. Cell Mol Neurobiol 2000; 20: 13-28.
18. Abbott NJ, Revest PA, Romero IA. Astrocyte-endothelial interaction: physiology and pathology. Neuropathol Appl Neurobiol 1992; 18: 424-433.
19. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987; 325: 253-257.
20. Omidi Y, Campbell L, Barar J, et al. Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res 2003; 990: 95-112.
21. Rubin LL, Hall DE, Porter S, et al. A cell culture model of the blood-brain barrier. J Cell Biol 1991; 115: 1725-1735.
22. Kageyama T, Nakamura M, Matsuo A, et al. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res 2000; 879: 115-121.
23. Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099-3108.
24. Motulsky H. Analyzing Data With GraphPad Prism. GraphPad Software, Inc: San Diego, 1999; 237-284.
25. Balabanov R, Beaumont T, Dore-Duffy P. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes. J Neurosci Res 1999; 55: 578-587.
26. El Hafny B, Chappey O, Piciotti M, et al. Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line. Neurosci Lett 1997; 236: 107-111.
27. Gaillard PJ, van dS I, Voorwinden LH, et al. Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier. Pharm Res 2000; 17: 1198-1205.
28. Isobe I, Watanabe T, Yotsuyanagi T, et al. Astrocytic contributions to blood-brain barrier (BBB) formation by endothelial cells: a possible use of aortic endothelial cell for in vitro BBB model. Neurochem Int 1996; 28: 523-533.
29. Sampaio-Maia B, Serrao MP, Soares-da-Silva P. Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells. Am J Physiol Cell Physiol 2001; 280: C333-C342.
30. Shennan DB, Thomson J, Gow IF, Travers MT, Barber MC. L-leucine transport in human breast cancer cells (MCF-7 and MDA-MB-231): kinetics, regulation by estrogen and molecular identity of the transporter. Biochim Biophys Acta 2004; 1664: 206-216.
31. Soares-da-Silva P, Serrao MP, Vieira-Coelho MA. Apical and basolateral uptake and intracellular fate of dopamine precursor L-dopa in LLC-PK1 cells. Am J Physiol 1998; 274: F243-F251.
32. Palacin M, Estevez R, Bertran J, Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 1998; 78: 969-1054.
33. Chishty M, Reichel A, Begley DJ, Abbott NJ. Glial induction of blood-brain barrier-like L-system amino acid transport in the ECV304 cell line. Glia 2002; 39: 99-104.
34. Brown J, Reading SJ, Jones S, et al. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 2000; 80: 37-45.
35. Scism JL, Laska DA, Horn JW, et al. Evaluation of an in vitro coculture model for the blood-brain barrier: comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources. In Vitro Cell Dev Biol Anim 1999; 35: 580-592.
36. Wagner CA, Broer A, Albers A, et al. The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xxenopus oocytes with a non-selective cation channel thatis regulated by the serine/threonine kinase sgk-1. J Physiol 2000; 526(Pt 1): 35-46.
37. Broer A, Friedrich B, Wagner CA, et al. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains. Biochem J 2001; 355: 725-731.
38. Shennan DB, Calvert DT, Travers MT, Kudo Y, Boyd CA. A study of L-leucine, L-phenylalanine and L-alanine transport in the perfused rat mammary gland: possible involvement of LAT1 and L AT2. Biochim Biophys Acta 2002; 1564: 133-139.
39. Uchino H, Kanai Y, Kim dK, et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 2002; 61: 729-737.
40. O'Kane RL, Hawkins RA. Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier. Am J Physiol Endocrinol Metab 2003; 285: 1167-1173.
41. Smith MW, Gumbleton M. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J Drug Target 2006; 14: 191-214.
42. Gee JR, Keller JN. Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int J Biochem Cell Biol 2005; 37: 1145-1150.
43. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 1990; 70: 43-77.